266 related articles for article (PubMed ID: 23060793)
21. Acute nicotine alteration of sensory memory impairment in smokers with schizophrenia.
Dulude L; Labelle A; Knott VJ
J Clin Psychopharmacol; 2010 Oct; 30(5):541-8. PubMed ID: 20814324
[TBL] [Abstract][Full Text] [Related]
22. The effects of a sub-anaesthetic dose of ketamine on human selective attention.
Oranje B; van Berckel BN; Kemner C; van Ree JM; Kahn RS; Verbaten MN
Neuropsychopharmacology; 2000 Mar; 22(3):293-302. PubMed ID: 10693157
[TBL] [Abstract][Full Text] [Related]
23. Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.
Rissling AJ; Park SH; Young JW; Rissling MB; Sugar CA; Sprock J; Mathias DJ; Pela M; Sharp RF; Braff DL; Light GA
Schizophr Res; 2013 May; 146(1-3):326-35. PubMed ID: 23490760
[TBL] [Abstract][Full Text] [Related]
24. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
Rosburg T; Kreitschmann-Andermahr I
Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
[TBL] [Abstract][Full Text] [Related]
25. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia.
Biagianti B; Roach BJ; Fisher M; Loewy R; Ford JM; Vinogradov S; Mathalon DH
Neuropsychiatr Electrophysiol; 2017; 3():. PubMed ID: 28845238
[TBL] [Abstract][Full Text] [Related]
26. A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex.
Cloke JM; Nguyen R; Chung BY; Wasserman DI; De Lisio S; Kim JC; Bailey CD; Winters BD
J Neurosci; 2016 Dec; 36(50):12570-12585. PubMed ID: 27974613
[TBL] [Abstract][Full Text] [Related]
27. Ketamine Affects Prediction Errors about Statistical Regularities: A Computational Single-Trial Analysis of the Mismatch Negativity.
Weber LA; Diaconescu AO; Mathys C; Schmidt A; Kometer M; Vollenweider F; Stephan KE
J Neurosci; 2020 Jul; 40(29):5658-5668. PubMed ID: 32561673
[TBL] [Abstract][Full Text] [Related]
28. N-methyl-D-aspartate receptor antagonism impairs sensory gating in the auditory cortex in response to speech stimuli.
de la Salle S; Choueiry J; McIntosh J; Bowers H; Ilivitsky V; Knott V
Psychopharmacology (Berl); 2022 Jul; 239(7):2155-2169. PubMed ID: 35348805
[TBL] [Abstract][Full Text] [Related]
29. Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia.
Hong LE; Schroeder M; Ross TJ; Buchholz B; Salmeron BJ; Wonodi I; Thaker GK; Stein EA
Schizophr Bull; 2011 Mar; 37(2):416-25. PubMed ID: 19713300
[TBL] [Abstract][Full Text] [Related]
30. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Heekeren K; Daumann J; Neukirch A; Stock C; Kawohl W; Norra C; Waberski TD; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2008 Jul; 199(1):77-88. PubMed ID: 18488201
[TBL] [Abstract][Full Text] [Related]
31. Neural effects of nicotine during auditory selective attention in smokers: an event-related potential study.
Knott V; Blais C; Scherling C; Camarda J; Millar A; Fisher D; McIntosh J
Neuropsychobiology; 2006; 53(3):115-26. PubMed ID: 16601362
[TBL] [Abstract][Full Text] [Related]
32. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.
Umbricht D; Vollenweider FX; Schmid L; Grübel C; Skrabo A; Huber T; Koller R
Neuropsychopharmacology; 2003 Jan; 28(1):170-81. PubMed ID: 12496954
[TBL] [Abstract][Full Text] [Related]
33. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
Javitt DC; Steinschneider M; Schroeder CE; Arezzo JC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11962-7. PubMed ID: 8876245
[TBL] [Abstract][Full Text] [Related]
34. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.
Jones GM; Sahakian BJ; Levy R; Warburton DM; Gray JA
Psychopharmacology (Berl); 1992; 108(4):485-94. PubMed ID: 1410164
[TBL] [Abstract][Full Text] [Related]
35. N-methyl-d-aspartate receptor antagonism modulates P300 event-related potentials and associated activity in salience and central executive networks.
de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Carroll B; Ilivitsky V; Knott V
Pharmacol Biochem Behav; 2021 Dec; 211():173287. PubMed ID: 34653398
[TBL] [Abstract][Full Text] [Related]
36. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
[TBL] [Abstract][Full Text] [Related]
37. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.
Buccafusco JJ; Terry AV
Biochem Pharmacol; 2009 Oct; 78(7):852-62. PubMed ID: 19577545
[TBL] [Abstract][Full Text] [Related]
38. α₄β₂ Nicotinic receptor stimulation of the GABAergic system within the orbitofrontal cortex ameliorates the severe crossmodal object recognition impairment in ketamine-treated rats: implications for cognitive dysfunction in schizophrenia.
Cloke JM; Winters BD
Neuropharmacology; 2015 Mar; 90():42-52. PubMed ID: 25460188
[TBL] [Abstract][Full Text] [Related]
39. Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects.
Hahn B; Shrieves ME; Olmstead CK; Yuille MB; Chiappelli JJ; Pereira EFR; Albuquerque EX; Fawcett WP
Psychopharmacology (Berl); 2020 Jan; 237(1):219-230. PubMed ID: 31686175
[TBL] [Abstract][Full Text] [Related]
40. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
Umbricht D; Koller R; Vollenweider FX; Schmid L
Biol Psychiatry; 2002 Mar; 51(5):400-6. PubMed ID: 11904134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
